BlackRock’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-113,000
Closed -$104M 5815
2026
Q1
$104M Buy
+113,000
New +$115M ﹤0.01% 2087
2025
Q3
Sell
-95,400
Closed -$74.4M 5533
2025
Q2
$74.4M Buy
95,400
+56,200
+143% +$43.7M ﹤0.01% 2234
2025
Q1
$32.4M Buy
+39,200
New +$32.6M ﹤0.01% 2633
2024
Q3
Sell
-82,500
Closed -$74.7M 5282
2024
Q2
$74.7M Sell
82,500
-44,200
-35% -$35.4M ﹤0.01% 2204
2024
Q1
$98.6M Buy
+126,700
New +$90.2M ﹤0.01% 2057
2023
Q4
Sell
-183,000
Closed -$98.3M 5426
2023
Q3
$98.3M Buy
183,000
+32,200
+21% +$16.6M ﹤0.01% 1994
2023
Q2
$70.7M Buy
+150,800
New +$63.2M ﹤0.01% 2280
2023
Q1
Sell
-378,700
Closed -$139M 5650
2022
Q4
$139M Sell
378,700
-194,400
-34% -$68.9M ﹤0.01% 1787
2022
Q3
$185M Buy
573,100
+30,000
+6% +$9.51M 0.01% 1534
2022
Q2
$176M Buy
+543,100
New +$163M 0.01% 1617
2022
Q1
Sell
-244,500
Closed -$67.5M 5872
2021
Q4
$67.5M Buy
244,500
+110,700
+83% +$28.1M ﹤0.01% 2456
2021
Q3
$30.9M Buy
+133,800
New +$33M ﹤0.01% 2991

Other funds holding LLY

BlackRock's LLY Position: Q2 2026 in Review

BlackRock increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $1.18B and bringing the position to 67,540,400 shares worth $81B. The position accounts for 1.2% of the portfolio, ranked #12.

BlackRock first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BlackRock held 67,540,400 shares of Eli Lilly worth $81B as of Q2 2026.
  • BlackRock bought 1,159,558 Eli Lilly shares in Q2 2026, an estimated $1.18B.
  • Eli Lilly made up 1.2% of BlackRock's portfolio in Q2 2026, its #12 holding.
  • BlackRock first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.